卡马西平与氯丙嗪治疗癔症临床对照研究  

A clinical comparative study on Carbamazepine and chlorpromazine in treating hysteria

作　　者：孙兆庆 祝英禄[1] 孙梦月 

机构地区：[1]山东省淄博市第五人民医院,山东淄博255100

出　　处：《海南医学》2006年第9期22-22,14,共2页Hainan Medical Journal

摘　　要：目的探讨卡马西平治疗癔症的疗效、副反应。方法将60例患者随机分为研究组、对照组,分别用卡马西平、氯丙嗪治疗,疗程8周,用BPRS及TESS量表评定疗效和副反应。结果治疗后2、4、6、8周末,BPRS量表分研究组明显低于对照组,TESS量表分对照组明显高于研究组。两组BPRS、TESS比较差异性均显著P<0.05。结论卡马西平治疗癔症疗效好、副反应少。Objective To explore the effects and side effects of Carbamazepine in treating hysteria. Methods 60 patients were randomly divided into two groups： Study group and control group. They were treated with Carbamazepine and Chlorpromazine respectively for 8 weeks. The effects and side effects were evaluated with Brief Psychiatric Rating Scale （BPRS） and Treatment Emergent Symptoms Scale （TESS）. Results at the end of 2th week, 4^th week, 6^th week, 8^th week, BPRS scores of the study group were obviously lower than the control group, and TESS scores of the control group were obviously higher than the study group. There was significant difference （p〈0.05）. Conclusion Carbamasepine has better effects and lighter side effects in treating hysteria.

关 键 词：卡马西平 癔症 氯丙嗪 治疗 

分 类 号：R749.7[医药卫生—神经病学与精神病学]